Q1 2020

Source filing unavailable

Q1 2020 · —

Revenue

$1.58M

no prior Q1 2019 on file

Net Income

-$3.24M

no prior Q1 2019 on file

EPS Diluted

-$0.02

no prior Q1 2019 on file

Operating Income-$114,453,000—

Operating Cash Flow-$111,167,000—

Free Cash Flowderived

Same quarter

no prior Q1 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR